Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
The study is published in Nature Communications and the researchers believe their discovery could lead to new drugs against infection and inflammation, for example in wound healing.
The toxins that are neutralised, known as lipopolysaccharides (LPS), come from the bacterial cell walls and generate an inflammatory reaction. The reaction is a necessary part of our immune defence system in which our bodies respond quickly and fight invasive bacteria. However, it can be over-activated and become harmful, as observed in infected skin wounds, infections in various organs, or in the case of bacteria spreading to the blood, which can lead to sepsis.
“We know from previous studies what the task of these peptides is but now we have mapped how they proceed in gradually reducing an inflammatory reaction”, says Artur Schmidtchen, professor of dermatology and venereology at Lund University and consultant physician at Skåne University Hospital in Lund.
“By use of advanced biophysics such as nuclear magnetic resonance analysis, combined with molecular modelling and biological studies we show that these peptides form a C-shaped structure which enables the capturing and inactivation of LPS. They also simultaneously interfere with receptor-mediated inflammatory responses”, adds Rathi Saravanan, senior research fellow at Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and first author of the study.
“Currently, most drugs aim to more or less completely block a target, such as a receptor. But that risks a deactivation of the immune defence system which can be detrimental and downright dangerous. The body’s own defence mechanisms proceed with greater caution in what is known as a transient manner: the peptides act on their target for a short time to reduce an inflammation towards normalisation. It is the natural functions of these peptides that we want to develop into new drugs”, says Artur Schmidtchen, who has been researching the field of innate immunity for over 20 years.
In addition, the peptides present in thrombin, a common blood protein, are multifunctional and can attack several targets, unlike current drugs.
The dermatology researchers now want to develop a peptide gel for improved wound healing in patient studies.
“That is the primary goal, but we will also be looking at the possibility of developing new drugs against infections in the eyes and various internal organs. This will become a new way of preventing both infection and inflammation without using antibiotics.”
The Latest on: Peptides
via Google News
The Latest on: Peptides
- Fish Collagen Peptides Market 2020 Global Share, Trend, Segmentation, Analysis and Forecast to 2026on October 6, 2020 at 2:06 pm
Fish Collagen Peptides Industry 2020. Market Overview. Fish collagen peptides are health supplements that are a good source of protein. Fish collagen peptides promote bones and jo ...
- How Peptides Are Madeon October 5, 2020 at 5:00 pm
What does body building, anti-aging cream and Bleomycin (a cancer drug) have in common? Peptides of course! Peptides are large molecules that are vital to life. If you were to take a protein and ...
- Global Biosimilar Therapeutic Peptides Market Value Expected To Reach $1.72 Billion By 2023on October 5, 2020 at 3:35 pm
The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77 billion in 2020 at a compound annual growth rate of -3.45%. The declin ...
- Cooperation between RNA and Proto-Proteinson October 2, 2020 at 11:50 am
A recent study supported in part by the NASA Astrobiology Program has shown that proto-peptides can interact directly with RNA in a way that helps stabilize both types of molecules.
- Global Collagen Peptides Market to Reach Up to $1,169.5 Million and Grow at a CAGR of 8.1% by 2027 - Exclusive Report [196 pages] by Research Diveon October 1, 2020 at 5:55 am
Based on source, the global collagen peptides market is segmented into bovine, porcine, marine, and poultry. The bovine segment held the largest market share in 2019 and is expected to continue ...
- Fish Collagen Peptides Market Share 2020 : Top Manufacturers, Industry Size, Regional Analysis, Types and Applications and Forecasts to 2026on September 27, 2020 at 8:18 pm
Selbyville, Delaware, Global Fish Collagen Peptides Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2026. Fish Collagen Peptides ...
- Collagen Peptides Market to 2027 – Amikozen Co., BSA Pharma, Collagen Solutions Plcon September 23, 2020 at 8:25 am
The collagen peptides market accounted for US$ 852.4 Mn in 2018 and is expected to grow at a CAGR of 10.9% during the forecast period 2019 – 2027, to account for US$ 2,129.9 Mn by 2027.
- Giant spider provides promise of pain relief for irritable bowel syndromeon September 21, 2020 at 9:23 am
Professor Lewis said spider venoms contain hundreds of mini-proteins known as peptides that can inhibit voltage-gated ion channels from opening. "Unfortunately these peptides aren't completely ...
via Bing News